Company intelligence / Profile preview

Aenova Group

Starnberg, Bavaria, Germany

Ownership: Private
Development stage: Other

Overview

Aenova provides end-to-end contract development and manufacturing services for pharmaceutical, consumer healthcare, veterinary health, and dietary supplement companies. It covers all major dosage forms—solid, semi-solid, liquid, sterile/nonsterile—and supports both high-potency and low-dosage products. The company operates globally with a strong presence in Europe and the US. No proprietary clinical results as it does not develop its own drugs.

Modalities: Small moleculeBiologicPeptidesDietary supplement (nutraceuticals)Intermediates
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Aenova Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aenova Group.

Explore the full profile